Credit: Tommie Morelos / Texas Tech University Health Sciences Center El Paso
Brad Bryan, Ph.D., a biomedical scientist at Texas Tech University Health Sciences Center El Paso, has conducted research on how propranolol can fight angiosarcoma and reduce tumor growth. His work is partly credited for propranolol achieving Orphan Drug Designation in Europe.